C1-2013-15111. Listing of Color Additives Exempt From Certification; Reactive Blue 246 and Reactive Blue 247 Copolymers; Confirmation of Effective Date
-
Start Preamble
Correction
In rule document 2013-15111, appearing on pages 37962-37963 in the issue of Tuesday, June 25, 2013, make the following correction:
On page 37962, in the section titled SUPPLEMENTARY INFORMATION, the first paragraph is corrected to read as set forth below:
In the Federal Register of April 1, 2013, we amended the color additive regulations in §§ 73.3100 and 73.3106 (21 CFR 73.3100 and 73.3106), respectively, to provide for the safe use of additional copolymers of 1,4-bis[(2-hydroxyethyl)amino]-9,10-anthracenedione bis(2-methyl-2-propenoic)ester (C.I. Reactive Blue 247) and additional copolymers of 1,4-bis[4-(2-methacryloxyethyl)phenylamino]anthraquinone (C.I. Reactive Blue 246), as color additives in contact lenses. We also corrected the nomenclature for Reactive Blue 247 by inserting “2-methyl” before “2-propenoic.”
End Preamble[FR Doc. C1-2013-15111 Filed 7-15-13; 8:45 am]
BILLING CODE 1505-01-D
Document Information
- Published:
- 07/16/2013
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Document Number:
- C1-2013-15111
- Pages:
- 42451-42451 (1 pages)
- Docket Numbers:
- Docket Nos. FDA-2011-C-0344 and FDA-2011-C-0463
- PDF File:
- c1-2013-15111.pdf
- Supporting Documents:
- » Medical Devices: Physical Medicine Devices: Classification of the Virtual Reality Behavioral Therapy Device for Pain Relief
- » Medical Devices: Physical Medicine Devices: Classification of the Electroencephalography-Driven Upper Extremity Powered Exerciser
- » Medical Devices: Cardiovascular Devices: Classification of the Hardware and Software for Optical Camera-Based Measurement of Pulse Rate, Heart Rate, Breathing Rate, and/or Respiratory Rate
- » Medical Devices: Orthopedic Devices: Classification of the Resorbable Shoulder Spacer
- » Agency Information Collection Activities; Proposals, Submissions, and Approvals: Designated New Animal Drugs for Minor Use and Minor Species
- » Agency Information Collection Activities; Proposals, Submissions, and Approvals: Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing
- CFR: (1)
- 21 CFR 73